159 related articles for article (PubMed ID: 17913045)
21. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
22. Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.
Carpagnano GE; Palladino GP; Lacedonia D; Koutelou A; Orlando S; Foschino-Barbaro MP
BMC Cancer; 2011 Jun; 11():226. PubMed ID: 21649887
[TBL] [Abstract][Full Text] [Related]
23. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Exp Oncol; 2012 Dec; 34(4):348-53. PubMed ID: 23302994
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: Clinical value of IL-11 in non-small cell lung cancer.
Wu J; Chen J; Lv X; Yang Q; Yao S; Zhang D; Chen J
Int J Biol Markers; 2021 Jun; 36(2):64-76. PubMed ID: 34142593
[TBL] [Abstract][Full Text] [Related]
25. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.
Carpagnano GE; Palladino GP; Gramiccioni C; Foschino Barbaro MP; Martinelli D
Lung Cancer; 2010 May; 68(2):305-7. PubMed ID: 20188432
[TBL] [Abstract][Full Text] [Related]
26. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
[TBL] [Abstract][Full Text] [Related]
27. Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge.
Carpagnano GE; Foschino Barbaro MP; Cagnazzo M; Di Gioia G; Giliberti T; Di Matteo C; Resta O
Chest; 2005 Nov; 128(5):3159-66. PubMed ID: 16304257
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
[TBL] [Abstract][Full Text] [Related]
29. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
30. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
31. Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.
Georgiades G; Myrianthefs P; Venetsanou K; Kythreoti A; Kyroudi A; Kittas C; Baltopoulos G
Lung; 2003; 181(1):35-47. PubMed ID: 12879338
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
33. Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients.
Goldoni M; Caglieri A; Corradi M; Poli D; Rusca M; Carbognani P; Mutti A
Int Arch Occup Environ Health; 2008 Feb; 81(4):487-93. PubMed ID: 17724608
[TBL] [Abstract][Full Text] [Related]
34. A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.
Guo J; Wang X; Wang Y; Wang L; Hua S
Lung Cancer; 2019 Sep; 135():47-55. PubMed ID: 31447002
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
[TBL] [Abstract][Full Text] [Related]
36. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():136-45. PubMed ID: 9337532
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of oxidative stress markers in exhaled breath condensate.
Chan HP; Tran V; Lewis C; Thomas PS
J Thorac Oncol; 2009 Feb; 4(2):172-8. PubMed ID: 19179892
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study.
Naumnik W; Naumnik B; Niewiarowska K; Ossolinska M; Chyczewska E
Adv Exp Med Biol; 2013; 788():341-8. PubMed ID: 23835996
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
Tran TA; Kallakury BV; Ambros RA; Ross JS
Cancer; 1998 Jul; 83(2):276-82. PubMed ID: 9669810
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
